Flemming Steen Jensen, See Remarks at Ascendis Pharma A/S (ASND), sold 19,460 shares at $238.49 ($4.6M) on 2026-05-11, disclosed to the SEC on 2026-05-12.
Open-market sale of $4.6M ASND by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.